← Back to Search

Transportation Service for Improving Wellness Metrics Related to Social Determinants of Health (ACTiN Trial)

N/A
Waitlist Available
Research Sponsored by John M. Salmon IV, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

ACTiN Trial Summary

This trial will test a new transportation model in small cities and rural areas to see if it improves transportation assets for people who use a community-based nonprofit health service. It will also measure if there are improvements in wellness metrics.

Who is the study for?
This trial is for adults living in Lynchburg, Virginia who are under-resourced, meaning they qualify for welfare programs like food stamps or Medicaid, or have an income at or below twice the Federal Poverty Threshold.Check my eligibility
What is being tested?
The study is testing a new transportation model called ACTiN designed to improve access to transport in small cities and rural areas. It will look at how this affects wellness based on annual health check standards and chronic disease metrics.See study design
What are the potential side effects?
Since this trial involves a transportation service rather than a medical intervention, there aren't typical side effects as with drugs; however, any unexpected negative impacts related to using the service will be monitored.

ACTiN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cancer screening success
Cost of transportation
Rides completed
+1 more
Secondary outcome measures
ADL
BMI
Blood Pressure
+14 more

ACTiN Trial Design

1Treatment groups
Experimental Treatment
Group I: Study armExperimental Treatment1 Intervention
Low resource, high risk individuals with limited transportation options as a social determinant of health.

Find a Location

Who is running the clinical trial?

John M. Salmon IV, MDLead Sponsor
John Salmon, MDStudy DirectorMedical Director, Lighthouse Community Health Center

Media Library

Transportation service Clinical Trial Eligibility Overview. Trial Name: NCT05510765 — N/A
Social Determinants of Health Research Study Groups: Study arm
Social Determinants of Health Clinical Trial 2023: Transportation service Highlights & Side Effects. Trial Name: NCT05510765 — N/A
Transportation service 2023 Treatment Timeline for Medical Study. Trial Name: NCT05510765 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the intended outcomes of this clinical experiment?

"This 12-month trial is designed to assess the effects of untreated disease(s). As secondary outcomes, Hgb A1c levels (hemoglobin A1C) will be measured at intake, 6 months, and 1 year. Cognitive function tests (CPCOG) and total number of prescribed medications will also be evaluated at those same intervals."

Answered by AI

Is there still an opportunity for people to join this experiment?

"As per the information on clinicaltrials.gov, this medical study is no longer recruiting participants. Initially posted on October 1st 2022 and last edited August 19th 2022, it has since been superseded by 7 other trials actively seeking volunteers at present."

Answered by AI
~20 spots leftby Apr 2025